VectivBio Holding AG (VECT) has a market capitalization of $1.06B and trades at $16.87. The 52-week range is 4.25-16.98.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8, Earnings Per Share (EPS) of $-2.12, annual revenue of $27.34M.
The stock has a beta of 0.10, operates in the Healthcare sector.
